Changes in self-reported cannabis use in the United States from 1979 to 2022

被引:0
|
作者
Caulkins, Jonathan P. [1 ,2 ]
机构
[1] Carnegie Mellon Univ, Stever Univ Prof Operat Res & Publ Policy, Heinz Coll, Pittsburgh, PA USA
[2] Carnegie Mellon Univ, Heinz Coll, 5000 Forbes Ave, Pittsburgh, PA 15213 USA
关键词
alcohol; cannabis; daily and near-daily use; drug policy; legalization; prevalence;
D O I
10.1111/add.16519
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background and aimsMultiple countries are considering revising cannabis policies. This study aimed to measure long-term trends in cannabis use in the United States and compare them with alcohol use.Design and settingSecondary analysis of United States general population survey data.ParticipantsThe national surveys had a total of 1 641 041 participants across 27 surveys from 1979 to 2022.MeasurementsRates of use reported to the US National Survey on Drug Use and Health and its predecessors are described, as are trends in days of use reported. Four milepost years are contrasted: 1979 (first available data and end of relatively liberal policies of the 1970s), 1992 (end of 12 years of conservative Reagan-Bush era policies), 2008 (last year before the Justice Department signaled explicit federal non-interference with state-level legalizations) and 2022 (most recent data available).FindingsReported cannabis use declined to a nadir in 1992, with partial recovery through 2008, and substantial increases since then, particularly for measures of more intensive use. Between 2008 and 2022, the per capita rate of reporting past-year use increased by 120%, and days of use reported per capita increased by 218% (in absolute terms from the annual equivalent of 2.3 to 8.1 billion days per year). From 1992 to 2022, there was a 15-fold increase in the per capita rate of reporting daily or near daily use. Whereas the 1992 survey recorded 10 times as many daily or near daily alcohol as cannabis users (8.9 vs. 0.9 M), the 2022 survey, for the first time, recorded more daily and near daily users of cannabis than alcohol (17.7 vs. 14.7 M). Far more people drink, but high-frequency drinking is less common. In 2022, the median drinker reported drinking on 4-5 days in the past month, versus 15-16 days in the past month for cannabis. In 2022, past-month cannabis consumers were almost four times as likely to report daily or near daily use (42.3% vs. 10.9%) and 7.4 times more likely to report daily use (28.2% vs. 3.8%).ConclusionsLong-term trends in cannabis use in the United States parallel corresponding changes in cannabis policy, with declines during periods of greater restriction and growth during periods of policy liberalization. A growing share of cannabis consumers report daily or near daily use, and their numbers now exceed the number of daily and near daily drinkers.
引用
收藏
页码:1648 / 1652
页数:5
相关论文
共 50 条
  • [1] Self-reported cannabis use and biomarkers of inflammation among adults in the United States
    Okafor, Chukwuemeka N.
    Li, Michael
    Paltzer, Jason
    [J]. BRAIN, BEHAVIOR, & IMMUNITY - HEALTH, 2020, 7
  • [2] Self-reported Medical and Nonmedical Cannabis Use Among Pregnant Women in the United States
    Volkow, Nora D.
    Han, Beth
    Compton, Wilson M.
    McCance-Katz, Elinore F.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (02): : 167 - 169
  • [3] Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States
    Wadsworth, Elle
    Goodman, Samantha
    Hammond, David
    [J]. JOURNAL OF PSYCHOACTIVE DRUGS, 2023, 55 (04) : 483 - 492
  • [4] Self-Reported Illicitly Manufactured Fentanyl Use and Associated Health and Substance Use Risks in the United States, 2022
    Oh, Sehun
    Cano, Manuel
    [J]. SUBSTANCE USE & MISUSE, 2024,
  • [5] Use of phosphodiesterase inhibitors and prevalence of self-reported glaucoma in the United States
    Chen, Stephanie P.
    Singh, Kuldev
    Lin, Shan C.
    [J]. PLOS ONE, 2017, 12 (08):
  • [6] The Use of eHealth Practices by United States Patients with Self-Reported Glaucoma
    Stagg, Brian C.
    Gupta, Divakar
    Ehrlich, Joshua R.
    Newman-Casey, Paula Anne
    Stein, Joshua D.
    Kawamoto, Kensaku
    Hess, Rachel
    [J]. OPHTHALMOLOGY GLAUCOMA, 2021, 4 (01): : 71 - 77
  • [7] SELF-REPORTED DEPRESSION AND HOSPITALIZATION FOR DEPRESSION IN UTAH COMPARED WITH THE UNITED STATES: 1979-2008.
    Merrill, R. M.
    Lyon, J. L.
    Read, M.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S56 - S56
  • [8] VALIDATION OF SELF-REPORTED CANNABIS USE BY URINE ANALYSIS
    MARTIN, GW
    WILKINSON, DA
    KAPUR, BM
    [J]. ADDICTIVE BEHAVIORS, 1988, 13 (02) : 147 - 150
  • [9] Changes in Self-Reported Depressive Symptoms Among Adults in the United States From 2005 to 2016
    Kauffman, Kelley
    Horvat Davey, Christine
    Dolata, Jacqueline
    Figueroa, Maria
    Gunzler, Douglas
    Huml, Anne
    Pencak, Julie
    Sajatovic, Martha
    Sehgal, Ashwini R.
    [J]. JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2021, 27 (02) : 148 - 155
  • [10] Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States
    Wadsworth, Elle
    Hines, Lindsey A.
    Hammond, David
    [J]. SUBSTANCE ABUSE, 2022, 43 (01) : 943 - 948